Increased levels of angiotensin II (Ang II) and activated matrix metalloproteinase 2 (MMP-2) produced by human aortic smooth muscle cells (human ASMCs) have recently been implicated in the pathogenesis of thoracic aortic aneurysm (TAA). Additionally, angiotensin II type 1 receptor (AT1R)-mediated extracellular signal-regulated kinase (ERK)1/2 activation contributes to TAA development in Marfan Syndrome. However, there is scant data regarding the relationship between Ang II and MMP-2 expression in human ASMCs. Therefore, we investigated the effect of Ang II on MMP-2 expression in human ASMCs and used Western blotting to identify the Ang II receptors and intracellular signaling pathways involved. Reverse transcription polymerase chain reaction (RT-PCR) and immunofluorescence data demonstrated that Ang II receptors were expressed on human ASMCs. Additionally, Ang II increased the expression of Ang II type 2 receptor (AT2R) but not AT1R at both the transcriptional and translational levels. Furthermore, Western blotting showed that Ang II increased MMP-2 expression in human ASMCs in a dose- and time-dependent manner. This response was completely inhibited by the AT1R inhibitor candesartan but not by the AT2R blocker PD123319. In addition, Ang II–induced upregulation of MMP-2 was mediated by the activation of ERK1/2, whereas p38 mitogen-activated protein kinase (p38 MAPK) and c-Jun N-terminal kinase (JNK) had no effect on this process. In conclusion, these results indicate that Ang II can increase the expression of MMP-2 via AT1 receptor and ERK1/2 signaling pathways in human ASMCs and suggest that antagonists of AT1R and ERK1/2 may be useful for treating TAAs.
JohanssonGMarkstromUSwedenborgJ. Ruptured thoracic aortic aneurysms: a study of incidence and mortality rates. J Vasc Surg1995; 21: 985–8.
2.
VisseRNagaseH. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res2003; 92: 827–39.
3.
RaffettoJDKhalilRA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol2008; 75: 14–14.
4.
SinhaIBethiSCroninPWilliamsDMRoelofsKAilawadiGHenkePKEagletonMJDeebGMPatelHJBerguerRStanleyJCUpchurchGRJr. A biologic basis for asymmetric growth in descending thoracic aortic aneurysms: a role for matrix metalloproteinase 9 and 2. J Vasc Surg2006; 43: 342–8.
5.
SeguraAMLunaREHoribaKStetler-StevensonWGMcAllisterHAJrWillersonJTFerransVJ. Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. Circulation1998; 98: 7–7.
6.
LongoGMXiongWGreinerTCZhaoYFiottiNBaxterBT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest2002; 110: 625–32.
7.
ThompsonRWHolmesDRMertensRALiaoSBotneyMDMechamRPWelgusHGParksWC. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest1995; 96: 318–26.
PatelMIMelroseJGhoshPApplebergM. Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. J Vasc Surg1996; 24: 82–92.
10.
LesauskaiteVTanganelliPSassiCNeriEDiciollaFIvanovieneLEpistolatoMCLalingaAVAlessandriniCSpinaD. Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: morphology, immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors. Hum Pathol2001; 32: 1003–11.
11.
TouyzRM. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol2005; 90: 449–55.
12.
LuHRateriDLBruemmerDCassisLADaughertyA. Involvement of the renin-angiotensin system in abdominal and thoracic aortic aneurysms. Clin Sci (Lond)2012; 123: 531–43.
13.
MoltzerEEssersJvan EschJHRoos-HesselinkJWDanserAH. The role of the renin-angiotensin system in thoracic aortic aneurysms: clinical implications. Pharmacol Ther2011; 131: 50–60.
14.
DaughertyARateriDLCharoIFOwensAPHowattDACassisLA. Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice. Clin Sci (Lond)2010; 118: 681–9.
15.
BruemmerDDaughertyALuHRateriDL. Relevance of angiotensin II-induced aortic pathologies in mice to human aortic aneurysms. Ann N Y Acad Sci2011; 1245: 7–10.
16.
TouyzRMDengLYHeGWuXHSchiffrinEL. Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases. J Hypertens1999; 17: 907–16.
17.
TakahashiTKawaharaYOkudaMUenoHTakeshitaAYokoyamaM. Angiotensin II stimulates mitogen-activated protein kinases and protein synthesis by a Ras-independent pathway in vascular smooth muscle cells. J Biol Chem1997; 272: 16018–22.
18.
LuchtefeldMGroteKGrothusenCBleySBandlowNSelleTStruberMHaverichABavendiekUDrexlerHSchiefferB. Angiotensin II induces MMP-2 in a p47phox-dependent manner. Biochem Biophys Res Commun2005; 328: 183–8.
19.
HamSALeeHHwangJSKangESYooTPaekKSDoJTParkCOhJWKimJHHanCWSeoHG. Activation of peroxisome proliferator-activated receptor delta inhibits angiotensin II-induced activation of matrix metalloproteinase-2 in vascular smooth muscle cells. J Vasc Res2014; 51: 221–30.
20.
JimenezEPerez de la BlancaEUrsoLGonzalezISalasJMontielM. Angiotensin II induces MMP 2 activity via FAK/JNK pathway in human endothelial cells. Biochem Biophys Res Commun2009; 380: 769–74.
21.
BrowatzkiMLarsenDPfeifferCAGehrkeSGSchmidtJKranzhoferAKatusHAKranzhoferR. Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner. J Vasc Res2005; 42: 415–23.
22.
WangMZhangJSpinettiGJiangLQMonticoneRZhaoDChengLKrawczykMTalanMPintusGLakattaEG. Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats. Am J Pathol2005; 167: 1429–42.
23.
PrattREDzauVJ. Pharmacological strategies to prevent restenosis: lessons learned from blockade of the renin-angiotensin system. Circulation1996; 93: 848–52.
24.
GuoRWYangLXWangHLiuBWangL. Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells. Regul Pept2008; 147: 37–44.
25.
de GodoyMARattanS. Translocation of AT1- and AT2-receptors by higher concentrations of angiotensin II in the smooth muscle cells of rat internal anal sphincter. J Pharmacol Exp Ther2006; 319: 1088–95.
26.
JingTWangHSrivenugopalKSHeGLiuJMiaoLHeY. Conditional expression of type 2 angiotensin II receptor in rat vascular smooth muscle cells reveals the interplay of the angiotensin system in matrix metalloproteinase 2 expression and vascular remodeling. Int J Mol Med2009; 24: 103–10.
27.
BrassardPAmiriFSchiffrinEL. Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries. Hypertension2005; 46: 598–606.
28.
FordCMLiSPickeringJG. Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells. Involvement of the AT(1) receptor, transforming growth factor-beta, and tyrosine phosphorylation. Arterioscler Thromb Vasc Biol1999; 19: 1843–51.
PonsMCousinsSWAlcazarOStrikerGEMarin-CastañoME. Angiotensin II-induced MMP-2 activity and MMP-14 and basigin protein expression are mediated via the angiotensin II receptor type 1-mitogen-activated protein kinase 1 pathway in retinal pigment epithelium: implications for age-related macular degeneration. Am J Pathol2011; 178: 2665–81.
31.
GhoshADiMustoPDEhrlichmanLKSadiqOMcEvoyBFutchkoJSHenkePKEliasonJLUpchurchGRJr. The role of extracellular signal-related kinase during abdominal aortic aneurysm formation. J Am Coll Surg2012; 215: 668–80 e.
32.
TouyzRMEl MabroukMHeGWuXHSchiffrinEL. Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediated signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells. Circ Res1999; 84: 505–1.
33.
ZhangYNaggarJCWelzigCMBeasleyDMoultonKSParkHJGalperJB. Simvastatin inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-knockout mice: possible role of ERK. Arterioscler Thromb Vasc Biol2009; 29: 1764–7.
34.
NagasawaAYoshimuraKSuzukiRMikamoAYamashitaOIkedaYTsuchidaMHamanoK. Important role of the angiotensin II pathway in producing matrix metalloproteinase-9 in human thoracic aortic aneurysms. J Surg Res2013; 183: 472.
35.
KimYHLeeSJSeoKWBaeJUParkSYKimEKBaeSSKimJHKimCD. PAF enhances MMP-2 production in rat aortic VSMCs via a beta-arrestin2-dependent ERK signaling pathway. J Lipid Res2013; 54: 2678–8.
36.
EhrlichmanLKFordJWRoelofsKJTedeschi-FilhoWFutchkoJSRamacciottiEEliasonJLHenkePKUpchurchGRJr. Gender-dependent differential phosphorylation in the ERK signaling pathway is associated with increased MMP2 activity in rat aortic smooth muscle cells. J Surg Res2010; 160: 18–2.
37.
DeguchiJMakuuchiMNakaokaTCollinsTTakuwaY. Angiotensin II stimulates platelet-derived growth factor-B chain expression in newborn rat vascular smooth muscle cells and neointimal cells through Ras, extracellular signal-regulated protein kinase, and c-Jun N-terminal protein kinase mechanisms. Circ Res1999; 85: 565–7.
38.
LeeHMLeeCKLeeSHRohHYBaeYMLeeKYLimJParkPJParkTKLeeYLWonKJKimB. p38 mitogen-activated protein kinase contributes to angiotensin II-stimulated migration of rat aortic smooth muscle cells. J Pharmacol Sci2007; 105: 74–8.
